Iopamidol

Revision as of 16:33, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
Jump to navigation Jump to search
Iopamidol
Clinical data
Pregnancy
category
  • US: B (No risk in non-human studies)
Routes of
administration
Intravascular
ATC code
Legal status
Legal status
Identifiers
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC17H22I3N3O8
Molar mass777.08 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Iopamidol (INN, tradenames Iopamiro, Isovue, and Iopamiron) is a nonionic, low-osmolar iodinated contrast agent, developed by Bracco.

It is available in various concentrations, from 200 to 370 mgI/mL.

Clinical uses

Iopamidol is primarily used in the following:[1]

  • Angiography throughout the cardiovascular system, including cerebral and peripheral arteriography, coronary arteriography and ventriculography, pediatric angiocardiography, selective visceral arteriography and aortography, peripheral venography (phlebography)
  • Adult and pediatric intravenous excretory urography and intravenous adult and pediatric contrast enhancement of computed tomographic (CECT) head and body imaging

References

  1. Bracco Diagnostic Inc. (2004). "Iopamidol (Isovue) prescribing information (revised April 2004)". DailyMed. U.S. National Library of Medicine. Retrieved 2008-03-28. Unknown parameter |month= ignored (help)

External links


Template:WH

Template:WS